January 26, 2021
Publication 01
ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein…
December 10, 2020
Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors
BARCELONA, December 10, 2020 – Splice Bio, a biotech company based on technology developed in…
September 15, 2020
ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio
ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein…
Recent Comments